Immunology Professor Jennifer Manilay and bioengineering Professor Joel Spencer are using a new grant from the National Institutes of Health (NIH) to expand a project they’ve been working on for the past two years — delving into the immune systems of living mice to see how B-cells develop under different circumstances.
Health psychology Professor Jennifer Hahn-Holbrook and incoming grad student Jessica Marino have a new study suggesting that the breastmilk of mothers who have recovered from COVID-19 contains strong antibodies to the virus.
Professor Michael Thompson doesn’t usually work in immunology or drug development. But his use of X-ray crystallography — research that visualizes the structures of protein molecules to better understand how they function — has taken him in a new direction.
About 70 percent of people with COVID-19 suddenly lose their sense of smell, although fewer of them seem to realize it, according to a new “living analysis” by a research team that includes a UC Merced graduate student.
A new coalition of universities and community partners across the state — including UC Merced —aims to address the COVID-19 pandemic in communities that are disproportionally affected.
Everyone will have opportunities to learn about collaborative research at the intersections of COVID-19 and topics related to the environment, health and equity through a series of online conference sessions this fall.
Having had the common cold appears to have programmed some people’s immune cells to recognize the coronavirus that causes COVID-19.
That discovery — by an immunology team that includes a UC Merced alumnus — could change scientists’ understanding of the virus behind the current pandemic.
Maybe now more than ever, scientists need to understand the immune system.
A new National Institutes of Health grant is funding a cross-disciplinary collaboration between bioengineering Professor Joel Spencer and immunology Professor Jennifer Manilay that will allow them to watch as immune-system cells develop in the bone marrow of a living mouse to gain insights into how they work.
A UC Merced researcher and her lab have unlocked one of the mysteries that could lead to treatments — or even cures — for prion diseases in mammals.
Prion diseases are a family of rare, progressive neurodegenerative disorders that affect both humans — such as with Creutzfeldt-Jakob disease or fatal familial insomnia — and animals, such as mad-cow disease. These disorders are usually rapidly progressive and always fatal, according to the Centers for Disease Control.
Breakthrough collaborative science by an interdisciplinary team of researchers brought together by computational biology Professor David Ardell promises a new approach for treating all types of infections.
Infections have become more dangerous in recent years because bacteria and parasites rapidly evolve resistance to the medicines.
